Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fu

Showing results (781-790 of 814) with videos related to

Pageof 82
Sort By:
Journal of Diabetes Investigation|March 26, 2018
Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation ProgramLinsey Gani, Eric Lau, Andrea Luk, et al.
The Lancet Regional Health. Western Pacific|February 14, 2023
Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) programLee-Ling Lim, Eric S H Lau, Alice P S Kong, et al.
JAMA Network Open|March 25, 2022
Effect of a Web-Based Management Guide on Risk Factors in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A JADE Randomized Clinical TrialJuliana C N Chan, Yotsapon Thewjitcharoen, Thy Khue Nguyen, et al.
JAMA Network Open|April 30, 2021
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical TrialLee-Ling Lim, Eric S H Lau, Amy W C Fu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 14, 2025
[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]C Y Sun, Z Cai, B Chen, et al.
Plos Medicine|October 2, 2020
Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysisLee-Ling Lim, Eric S H Lau, Risa Ozaki, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 15, 2024
Glycaemic control and microvascular complications among paediatric type 2 diabetes mellitus patients in Hong Kong at 2 years after diagnosisW I Yam, S M Y Wong, P T Cheung, et al.
JAMA Network Open|January 4, 2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesJessica E Hawley, Tianyi Sun, David D Chism, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Physical Review Letters|April 23, 2021
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.46 ppmB Abi, T Albahri, S Al-Kilani, et al.
Pageof 82

Showing results (781-790 of 814) with videos related to

Sort By:
Pageof 82
Journal of Diabetes Investigation|March 26, 2018
Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation ProgramLinsey Gani, Eric Lau, Andrea Luk, et al.
The Lancet Regional Health. Western Pacific|February 14, 2023
Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) programLee-Ling Lim, Eric S H Lau, Alice P S Kong, et al.
JAMA Network Open|March 25, 2022
Effect of a Web-Based Management Guide on Risk Factors in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A JADE Randomized Clinical TrialJuliana C N Chan, Yotsapon Thewjitcharoen, Thy Khue Nguyen, et al.
JAMA Network Open|April 30, 2021
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical TrialLee-Ling Lim, Eric S H Lau, Amy W C Fu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 14, 2025
[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]C Y Sun, Z Cai, B Chen, et al.
Plos Medicine|October 2, 2020
Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysisLee-Ling Lim, Eric S H Lau, Risa Ozaki, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 15, 2024
Glycaemic control and microvascular complications among paediatric type 2 diabetes mellitus patients in Hong Kong at 2 years after diagnosisW I Yam, S M Y Wong, P T Cheung, et al.
JAMA Network Open|January 4, 2022
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesJessica E Hawley, Tianyi Sun, David D Chism, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Physical Review Letters|April 23, 2021
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.46 ppmB Abi, T Albahri, S Al-Kilani, et al.
Pageof 82